Farringdon Capital, Ltd. Zoetis Inc. Transaction History
Farringdon Capital, Ltd.
- $298 Billion
- Q2 2025
A detailed history of Farringdon Capital, Ltd. transactions in Zoetis Inc. stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 10,627 shares of ZTS stock, worth $1.56 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
10,627Holding current value
$1.56 Million% of portfolio
0.56%Shares
1 transactions
Others Institutions Holding ZTS
# of Institutions
2,130Shares Held
430MCall Options Held
1.47MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA41.9MShares$6.13 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.39 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$2.89 Billion0.12% of portfolio
-
Morgan Stanley New York, NY17.7MShares$2.59 Billion0.19% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.33 Billion2.21% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $68.5B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...